Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 398

1.

In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury.

Gorgoraptis N, Li LM, Whittington A, Zimmerman KA, Maclean LM, McLeod C, Ross E, Heslegrave A, Zetterberg H, Passchier J, Matthews PM, Gunn RN, McMillan TM, Sharp DJ.

Sci Transl Med. 2019 Sep 4;11(508). pii: eaaw1993. doi: 10.1126/scitranslmed.aaw1993.

PMID:
31484787
2.

Chronic inflammation in multiple sclerosis - seeing what was always there.

Matthews PM.

Nat Rev Neurol. 2019 Aug 16. doi: 10.1038/s41582-019-0240-y. [Epub ahead of print] Review.

PMID:
31420598
3.

New alcohol-related genes suggest shared genetic mechanisms with neuropsychiatric disorders.

Evangelou E, Gao H, Chu C, Ntritsos G, Blakeley P, Butts AR, Pazoki R, Suzuki H, Koskeridis F, Yiorkas AM, Karaman I, Elliott J, Luo Q, Aeschbacher S, Bartz TM, Baumeister SE, Braund PS, Brown MR, Brody JA, Clarke TK, Dimou N, Faul JD, Homuth G, Jackson AU, Kentistou KA, Joshi PK, Lemaitre RN, Lind PA, Lyytikäinen LP, Mangino M, Milaneschi Y, Nelson CP, Nolte IM, Perälä MM, Polasek O, Porteous D, Ratliff SM, Smith JA, Stančáková A, Teumer A, Tuominen S, Thériault S, Vangipurapu J, Whitfield JB, Wood A, Yao J, Yu B, Zhao W, Arking DE, Auvinen J, Liu C, Männikkö M, Risch L, Rotter JI, Snieder H, Veijola J, Blakemore AI, Boehnke M, Campbell H, Conen D, Eriksson JG, Grabe HJ, Guo X, van der Harst P, Hartman CA, Hayward C, Heath AC, Jarvelin MR, Kähönen M, Kardia SLR, Kühne M, Kuusisto J, Laakso M, Lahti J, Lehtimäki T, McIntosh AM, Mohlke KL, Morrison AC, Martin NG, Oldehinkel AJ, Penninx BWJH, Psaty BM, Raitakari OT, Rudan I, Samani NJ, Scott LJ, Spector TD, Verweij N, Weir DR, Wilson JF, Levy D, Tzoulaki I, Bell JD, Matthews PM, Rothenfluh A, Desrivières S, Schumann G, Elliott P.

Nat Hum Behav. 2019 Sep;3(9):950-961. doi: 10.1038/s41562-019-0653-z. Epub 2019 Jul 29.

PMID:
31358974
4.

Breaking the cycle: Reversal of flux in the tricarboxylic acid cycle by dimethyl fumarate.

Gafson AR, Savva C, Thorne T, David M, Gomez-Romero M, Lewis MR, Nicholas R, Heslegrave A, Zetterberg H, Matthews PM.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 22;6(3):e562. doi: 10.1212/NXI.0000000000000562. eCollection 2019 May.

5.

Towards a standard MRI protocol for multiple sclerosis across the UK.

Schmierer K, Campion T, Sinclair A, van Hecke W, Matthews PM, Wattjes MP.

Br J Radiol. 2019 Sep;92(1101):20180926. doi: 10.1259/bjr.20180926. Epub 2019 May 14. Review.

PMID:
30994035
6.

Automated quality control in image segmentation: application to the UK Biobank cardiovascular magnetic resonance imaging study.

Robinson R, Valindria VV, Bai W, Oktay O, Kainz B, Suzuki H, Sanghvi MM, Aung N, Paiva JM, Zemrak F, Fung K, Lukaschuk E, Lee AM, Carapella V, Kim YJ, Piechnik SK, Neubauer S, Petersen SE, Page C, Matthews PM, Rueckert D, Glocker B.

J Cardiovasc Magn Reson. 2019 Mar 14;21(1):18. doi: 10.1186/s12968-019-0523-x.

7.

Lipoprotein markers associated with disability from multiple sclerosis.

Gafson AR, Thorne T, McKechnie CIJ, Jimenez B, Nicholas R, Matthews PM.

Sci Rep. 2018 Nov 19;8(1):17026. doi: 10.1038/s41598-018-35232-7.

8.

Learning-Based Quality Control for Cardiac MR Images.

Tarroni G, Oktay O, Bai W, Schuh A, Suzuki H, Passerat-Palmbach J, de Marvao A, O'Regan DP, Cook S, Glocker B, Matthews PM, Rueckert D.

IEEE Trans Med Imaging. 2019 May;38(5):1127-1138. doi: 10.1109/TMI.2018.2878509. Epub 2018 Nov 1.

9.

Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS.

Gafson AR, Kim K, Cencioni MT, van Hecke W, Nicholas R, Baranzini SE, Matthews PM.

Neurol Neuroimmunol Neuroinflamm. 2018 Jun 12;5(4):e470. doi: 10.1212/NXI.0000000000000470. eCollection 2018 Jul.

10.

Automated cardiovascular magnetic resonance image analysis with fully convolutional networks.

Bai W, Sinclair M, Tarroni G, Oktay O, Rajchl M, Vaillant G, Lee AM, Aung N, Lukaschuk E, Sanghvi MM, Zemrak F, Fung K, Paiva JM, Carapella V, Kim YJ, Suzuki H, Kainz B, Matthews PM, Petersen SE, Piechnik SK, Neubauer S, Glocker B, Rueckert D.

J Cardiovasc Magn Reson. 2018 Sep 14;20(1):65. doi: 10.1186/s12968-018-0471-x.

11.

Unravelling the GSK3β-related genotypic interaction network influencing hippocampal volume in recurrent major depressive disorder.

Inkster B, Simmons A, Cole JH, Schoof E, Linding R, Nichols T, Muglia P, Holsboer F, Sämann PG, McGuffin P, Fu CHY, Miskowiak K, Matthews PM, Zai G, Nicodemus K.

Psychiatr Genet. 2018 Oct;28(5):77-84. doi: 10.1097/YPG.0000000000000203.

12.

Long term effect of primary health care training on HIV testing: A quasi-experimental evaluation of the Sexual Health in Practice (SHIP) intervention.

Pillay K, Gardner M, Gould A, Otiti S, Mullineux J, Bärnighausen T, Matthews PM.

PLoS One. 2018 Aug 1;13(8):e0199891. doi: 10.1371/journal.pone.0199891. eCollection 2018.

13.

Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis.

Supratak A, Datta G, Gafson AR, Nicholas R, Guo Y, Matthews PM.

Front Neurol. 2018 Jul 13;9:561. doi: 10.3389/fneur.2018.00561. eCollection 2018.

14.

Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases.

Ntusi NAB, Francis JM, Sever E, Liu A, Piechnik SK, Ferreira VM, Matthews PM, Robson MD, Wordsworth PB, Neubauer S, Karamitsos TD.

Int J Cardiol. 2018 Nov 1;270:253-259. doi: 10.1016/j.ijcard.2018.06.099. Epub 2018 Jun 25.

PMID:
30017519
15.

Impact of detecting potentially serious incidental findings during multi-modal imaging.

Gibson LM, Littlejohns TJ, Adamska L, Garratt S, Doherty N; UK Biobank Imaging Working Group, Wardlaw JM, Maskell G, Parker M, Brownsword R, Matthews PM, Collins R, Allen NE, Sellors J, Sudlow CL.

Wellcome Open Res. 2017 Nov 30;2:114. doi: 10.12688/wellcomeopenres.13181.3. eCollection 2017.

16.

Distinguishable brain networks relate disease susceptibility to symptom expression in schizophrenia.

Liu Z, Zhang J, Zhang K, Zhang J, Li X, Cheng W, Li M, Zhao L, Deng W, Guo W, Ma X, Wang Q, Matthews PM, Feng J, Li T.

Hum Brain Mapp. 2018 Sep;39(9):3503-3515. doi: 10.1002/hbm.24190. Epub 2018 Apr 24.

17.

Semi-Automated Analysis of Diaphragmatic Motion with Dynamic Magnetic Resonance Imaging in Healthy Controls and Non-Ambulant Subjects with Duchenne Muscular Dystrophy.

Bishop CA, Ricotti V, Sinclair CDJ, Evans MRB, Butler JW, Morrow JM, Hanna MG, Matthews PM, Yousry TA, Muntoni F, Thornton JS, Newbould RD, Janiczek RL.

Front Neurol. 2018 Jan 26;9:9. doi: 10.3389/fneur.2018.00009. eCollection 2018.

18.

Cardiovascular magnetic resonance characterization of myocardial and vascular function in rheumatoid arthritis patients.

Ntusi NAB, Francis JM, Gumedze F, Karvounis H, Matthews PM, Wordsworth PB, Neubauer S, Karamitsos TD.

Hellenic J Cardiol. 2019 Jan - Feb;60(1):28-35. doi: 10.1016/j.hjc.2018.01.008. Epub 2018 Jan 31.

19.

Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration.

Scott G, Zetterberg H, Jolly A, Cole JH, De Simoni S, Jenkins PO, Feeney C, Owen DR, Lingford-Hughes A, Howes O, Patel MC, Goldstone AP, Gunn RN, Blennow K, Matthews PM, Sharp DJ.

Brain. 2018 Feb 1;141(2):459-471. doi: 10.1093/brain/awx339.

20.

Achievements and obstacles of remyelinating therapies in multiple sclerosis.

Stangel M, Kuhlmann T, Matthews PM, Kilpatrick TJ.

Nat Rev Neurol. 2017 Dec;13(12):742-754. doi: 10.1038/nrneurol.2017.139. Epub 2017 Nov 17. Review.

21.

Abnormal brain white matter microstructure is associated with both pre-hypertension and hypertension.

Suzuki H, Gao H, Bai W, Evangelou E, Glocker B, O'Regan DP, Elliott P, Matthews PM.

PLoS One. 2017 Nov 16;12(11):e0187600. doi: 10.1371/journal.pone.0187600. eCollection 2017.

22.

Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank.

Alfaro-Almagro F, Jenkinson M, Bangerter NK, Andersson JLR, Griffanti L, Douaud G, Sotiropoulos SN, Jbabdi S, Hernandez-Fernandez M, Vallee E, Vidaurre D, Webster M, McCarthy P, Rorden C, Daducci A, Alexander DC, Zhang H, Dragonu I, Matthews PM, Miller KL, Smith SM.

Neuroimage. 2018 Feb 1;166:400-424. doi: 10.1016/j.neuroimage.2017.10.034. Epub 2017 Oct 24.

23.

TSPO mutations in rats and a human polymorphism impair the rate of steroid synthesis.

Owen DR, Fan J, Campioli E, Venugopal S, Midzak A, Daly E, Harlay A, Issop L, Libri V, Kalogiannopoulou D, Oliver E, Gallego-Colon E, Colasanti A, Huson L, Rabiner EA, Suppiah P, Essagian C, Matthews PM, Papadopoulos V.

Biochem J. 2017 Nov 21;474(23):3985-3999. doi: 10.1042/BCJ20170648.

24.

Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.

Datta G, Colasanti A, Rabiner EA, Gunn RN, Malik O, Ciccarelli O, Nicholas R, Van Vlierberghe E, Van Hecke W, Searle G, Santos-Ribeiro A, Matthews PM.

Brain. 2017 Nov 1;140(11):2927-2938. doi: 10.1093/brain/awx228.

25.

Protocol and quality assurance for carotid imaging in 100,000 participants of UK Biobank: development and assessment.

Coffey S, Lewandowski AJ, Garratt S, Meijer R, Lynum S, Bedi R, Paterson J, Yaqub M, Noble JA, Neubauer S, Petersen SE, Allen N, Sudlow C, Collins R, Matthews PM, Leeson P.

Eur J Prev Cardiol. 2017 Nov;24(17):1799-1806. doi: 10.1177/2047487317732273. Epub 2017 Sep 19.

26.

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.

LaRocca NG, Hudson LD, Rudick R, Amtmann D, Balcer L, Benedict R, Bermel R, Chang I, Chiaravalloti ND, Chin P, Cohen JA, Cutter GR, Davis MD, DeLuca J, Feys P, Francis G, Goldman MD, Hartley E, Kapoor R, Lublin F, Lundstrom G, Matthews PM, Mayo N, Meibach R, Miller DM, Motl RW, Mowry EM, Naismith R, Neville J, Panagoulias J, Panzara M, Phillips G, Robbins A, Sidovar MF, Smith KE, Sperling B, Uitdehaag BM, Weaver J; Multiple Sclerosis Outcome Assessments Consortium (MSOAC).

Mult Scler. 2018 Oct;24(11):1469-1484. doi: 10.1177/1352458517723718. Epub 2017 Aug 11. Review.

27.

Mixed Neural Network Approach for Temporal Sleep Stage Classification.

Dong H, Supratak A, Pan W, Wu C, Matthews PM, Guo Y.

IEEE Trans Neural Syst Rehabil Eng. 2018 Feb;26(2):324-333. doi: 10.1109/TNSRE.2017.2733220. Epub 2017 Jul 28.

28.

Advanced MRI measures like DTI or fMRI should be outcome measures in future clinical trials - NO.

Matthews PM.

Mult Scler. 2017 Oct;23(11):1456-1458. doi: 10.1177/1352458517713345. Epub 2017 Jun 30. No abstract available.

29.

Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans.

Owen DR, Narayan N, Wells L, Healy L, Smyth E, Rabiner EA, Galloway D, Williams JB, Lehr J, Mandhair H, Peferoen LA, Taylor PC, Amor S, Antel JP, Matthews PM, Moore CS.

J Cereb Blood Flow Metab. 2017 Aug;37(8):2679-2690. doi: 10.1177/0271678X17710182. Epub 2017 May 22.

30.

Correction: Characterisation of liver fat in the UK Biobank cohort.

Wilman HR, Kelly M, Garratt S, Matthews PM, Milanesi M, Herlihy A, Gyngell M, Neubauer S, Bell JD, Banerjee R, Thomas EL.

PLoS One. 2017 Apr 26;12(4):e0176867. doi: 10.1371/journal.pone.0176867. eCollection 2017.

31.

11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis.

Datta G, Colasanti A, Kalk N, Owen D, Scott G, Rabiner EA, Gunn RN, Lingford-Hughes A, Malik O, Ciccarelli O, Nicholas R, Nei L, Battaglini M, Stefano ND, Matthews PM.

J Nucl Med. 2017 Sep;58(9):1477-1482. doi: 10.2967/jnumed.116.187161. Epub 2017 Mar 16.

32.

A new soft material based in-the-ear EEG recording technique.

Hao Dong, Matthews PM, Guo Y.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:5709-5712. doi: 10.1109/EMBC.2016.7592023.

33.

Characterisation of liver fat in the UK Biobank cohort.

Wilman HR, Kelly M, Garratt S, Matthews PM, Milanesi M, Herlihy A, Gyngell M, Neubauer S, Bell JD, Banerjee R, Thomas EL.

PLoS One. 2017 Feb 27;12(2):e0172921. doi: 10.1371/journal.pone.0172921. eCollection 2017. Erratum in: PLoS One. 2017 Apr 26;12 (4):e0176867.

34.

Improving data availability for brain image biobanking in healthy subjects: Practice-based suggestions from an international multidisciplinary working group.

BRAINS (Brain Imaging in Normal Subjects) Expert Working Group, Shenkin SD, Pernet C, Nichols TE, Poline JB, Matthews PM, van der Lugt A, Mackay C, Lanyon L, Mazoyer B, Boardman JP, Thompson PM, Fox N, Marcus DS, Sheikh A, Cox SR, Anblagan D, Job DE, Dickie DA, Rodriguez D, Wardlaw JM.

Neuroimage. 2017 Jun;153:399-409. doi: 10.1016/j.neuroimage.2017.02.030. Epub 2017 Feb 14.

35.

Scanning the horizon: towards transparent and reproducible neuroimaging research.

Poldrack RA, Baker CI, Durnez J, Gorgolewski KJ, Matthews PM, Munafò MR, Nichols TE, Poline JB, Vul E, Yarkoni T.

Nat Rev Neurosci. 2017 Feb;18(2):115-126. doi: 10.1038/nrn.2016.167. Epub 2017 Jan 5. Review.

36.

tranSMART-XNAT Connector tranSMART-XNAT connector-image selection based on clinical phenotypes and genetic profiles.

He S, Yong M, Matthews PM, Guo Y.

Bioinformatics. 2017 Mar 1;33(5):787-788. doi: 10.1093/bioinformatics/btw714.

37.

Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis.

Datta G, Violante IR, Scott G, Zimmerman K, Santos-Ribeiro A, Rabiner EA, Gunn RN, Malik O, Ciccarelli O, Nicholas R, Matthews PM.

Mult Scler. 2017 Oct;23(11):1469-1478. doi: 10.1177/1352458516681504. Epub 2016 Dec 7.

38.

Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions.

Bishop CA, Newbould RD, Lee JS, Honeyfield L, Quest R, Colasanti A, Ali R, Mattoscio M, Cortese A, Nicholas R, Matthews PM, Muraro PA, Waldman AD.

Neuroimage Clin. 2016 Nov 9;13:9-15. eCollection 2017.

39.

Inferring Individual-Level Variations in the Functional Parcellation of the Cerebral Cortex.

Nie L, Matthews PM, Guo Y.

IEEE Trans Biomed Eng. 2016 Dec;63(12):2505-2517.

40.

Multimodal population brain imaging in the UK Biobank prospective epidemiological study.

Miller KL, Alfaro-Almagro F, Bangerter NK, Thomas DL, Yacoub E, Xu J, Bartsch AJ, Jbabdi S, Sotiropoulos SN, Andersson JL, Griffanti L, Douaud G, Okell TW, Weale P, Dragonu I, Garratt S, Hudson S, Collins R, Jenkinson M, Matthews PM, Smith SM.

Nat Neurosci. 2016 Nov;19(11):1523-1536. doi: 10.1038/nn.4393. Epub 2016 Sep 19.

41.

Role of 18F-fluorodeoxyglucose Positron Emission Tomography in the Monitoring of Inflammatory Activity in Crohn's Disease.

Russo EA, Khan S, Janisch R, Gunn RN, Rabiner EA, Taylor SA, Matthews PM, Orchard TR.

Inflamm Bowel Dis. 2016 Nov;22(11):2619-2629.

PMID:
27753695
42.

Personalised medicine for multiple sclerosis care.

Gafson A, Craner MJ, Matthews PM.

Mult Scler. 2017 Mar;23(3):362-369. doi: 10.1177/1352458516672017. Epub 2016 Sep 28. Review.

43.

Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.

Ricotti V, Evans MR, Sinclair CD, Butler JW, Ridout DA, Hogrel JY, Emira A, Morrow JM, Reilly MM, Hanna MG, Janiczek RL, Matthews PM, Yousry TA, Muntoni F, Thornton JS.

PLoS One. 2016 Sep 20;11(9):e0162542. doi: 10.1371/journal.pone.0162542. eCollection 2016.

44.

Corrigendum to "Abnormal frontostriatal connectivity in adolescent-onset schizophrenia and its relationship to cognitive functioning" [Eur. Psychiatry 35C (2016) 32-38].

James A, Joyce E, Lunn D, Hough M, Kenny L, Ghataorhe P, Fernandes HM, Matthews PM, Zarei M.

Eur Psychiatry. 2016 Oct;38:22. doi: 10.1016/j.eurpsy.2016.07.001. Epub 2016 Sep 8. No abstract available.

PMID:
27614143
45.

Clinical Concepts Emerging from fMRI Functional Connectomics.

Matthews PM, Hampshire A.

Neuron. 2016 Aug 3;91(3):511-28. doi: 10.1016/j.neuron.2016.07.031. Review.

46.

A Comparison of Magnetization Transfer Methods to Assess Brain and Cervical Cord Microstructure in Multiple Sclerosis.

Lema A, Bishop C, Malik O, Mattoscio M, Ali R, Nicholas R, Muraro PA, Matthews PM, Waldman AD, Newbould RD.

J Neuroimaging. 2017 Mar;27(2):221-226. doi: 10.1111/jon.12377. Epub 2016 Aug 5.

47.

Better together for better dementia research and care.

Lovestone S, Rossor M, Gallacher J, Ritchie C, Burn D, Hyslop PS, Mackay C, Matthews PM, Ballard C, Georges J.

Lancet Psychiatry. 2016 Jun;3(6):503-4. doi: 10.1016/S2215-0366(16)30090-6. Epub 2016 May 17. No abstract available.

PMID:
27198805
48.

Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease.

De Guio F, Jouvent E, Biessels GJ, Black SE, Brayne C, Chen C, Cordonnier C, De Leeuw FE, Dichgans M, Doubal F, Duering M, Dufouil C, Duzel E, Fazekas F, Hachinski V, Ikram MA, Linn J, Matthews PM, Mazoyer B, Mok V, Norrving B, O'Brien JT, Pantoni L, Ropele S, Sachdev P, Schmidt R, Seshadri S, Smith EE, Sposato LA, Stephan B, Swartz RH, Tzourio C, van Buchem M, van der Lugt A, van Oostenbrugge R, Vernooij MW, Viswanathan A, Werring D, Wollenweber F, Wardlaw JM, Chabriat H.

J Cereb Blood Flow Metab. 2016 Aug;36(8):1319-37. doi: 10.1177/0271678X16647396. Epub 2016 May 11. Review.

49.

A pilot study of the effect of short-term escitalopram treatment on brain metabolites and gamma-oscillations in healthy subjects.

Maron E, Near J, Wallis G, Stokes M, Matthews PM, Nutt DJ.

J Psychopharmacol. 2016 Jun;30(6):579-80. doi: 10.1177/0269881116636108. No abstract available.

50.

Design, Synthesis, and Evaluation of Fluorinated Radioligands for Myelin Imaging.

Tiwari AD, Wu C, Zhu J, Zhang S, Zhu J, Wang WR, Zhang J, Tatsuoka C, Matthews PM, Miller RH, Wang Y.

J Med Chem. 2016 Apr 28;59(8):3705-18. doi: 10.1021/acs.jmedchem.5b01858. Epub 2016 Apr 12.

PMID:
27070324

Supplemental Content

Loading ...
Support Center